Member Info for goldust88

Arden partners says buy -target 9.5

Taser thanks for link Smon Cole interview on there was very informative-once they get to breakeven the 70% plus margins will really pull in the profits-7DIG could really be be a big winner over the next few years.

Rns 7 Dec 2017---Director/PDMR Shareholdings

The Company was notified on 28 November 2017 of the following purchase of ordinary shares of 0.2 pence each ("Ordinary Shares") on that day by a director of the Company.

Colin Hutchinson, Chief Executive Officer, acquired 300,000 Ordinary Shares at a price of 1.743 pence per share. Following this transaction, Colin Hutchinson's shareholding is 1,570,370 Ordinary Shares, representing 0.07% of the issued share capital of the Company. In addition, he holds options over 69,261,652 shares at an average strike price of 1.8973 pence. Therefore, including share options, he has an interest in 70,832,022 shares representing 2.93% of the fully diluted share capital of the Company.

As you can see Colin needs about 1.8p a share to break even on his shareholding so cant see him agreeing a deal below this.

This has 2p + written all over it

But this could be the other contract that has been mentioned-now that would be something if both come in. We would be talking nearer a £1.00 per share

WSG Still way to low a price on tiny volume-this has way to go yet as some serious buys start soon

Price moving up slowly on small volume today as news sinks in. Share price has loads to go as investors begin to realise that contract could well be on cards soon with huge poentail of the further 60 airports in Iran

RNS---- news in this morning's RNS shows that progress is being made to get this Iran contract and not too many obstacles remain. Loan note from someone in the know indicates to me that that the Iran contract will be tied up sooner that most think.
Before Trump interfered WSG was trading in the 20-25p range with a potenial of 60p + on signing.
At todays price of 9p thats a potential 6 bagger,have doubled my holding.

Shore capitals valuation at 25p is a 4 baggger,maybe a bit high but it does look like contract pretty assured now and should easily be 18-20p on contract award.
Results in October sometime-now is a chance to double your money and more- watch this start to move.

Yep this is obviously his game plan time to buy is now before the herd catch on..

Starting to move up as expected.Still only valued at a tiny £11 million
Trump has done the usual, now will he arrange meet with Iran's President Rouhani to save the world-same as North Korea ? His usual tactics.You never know.That would be good for WSG and for the share price.

Excellent update all looks very good indeed.
This share is way below the radar for most investors but look at the share price growth over a few years.
Biome has got enormous potential if they can secure the right deals for its biodegradeable stuff. The share price could easily double again and again. I'm prepared to be patient for a cou[le of years.

Very soon WSG could announce the go ahead for the IRAN contract and later in the year another contract to add to this as mentioned in recent RNS. This would see the share price shoot above 50p, maybe a lot more.. The share price has drifted to the current 9.2p as time passes on but the potential remains the same and contract news could break any day now as WSG works frantically behind the scenes to clear up the remaining obsticles.
My view is that todays price offers a fantastic bet on making serious gains in a relatively short timespan and I have bought in on Friday.
There are not many shares out there that offer a 5+bagger gain and this is one of them,however if you leave your investing till news comes out you will miss the boat.
Buy.

Mark I agree with you, this announcement could be just the spark to set this share alight. With a huge potential acrearage, drilling this summer, very low share price and profitable- IGAS has all the ingredients to be big winner .

Great news today on final PK trials-expect an announcement very soon on licencee deal.. Now with the higher dose shown to be effective and safe the potential sales value of $Billion pa could be a lot higher if this is included. Price now way to cheap based on these results as potential now nearing reality.

Latest interview just to refresh all on what's due here-very soon http://youtu.be/IPxRKqMPfeQ

Volume of trades increasing pm today and share price moving up a little as we move towards the 13th,letssee if this interest continues to morrow.

My own opinion is that when the outlicencing deal is announced the terms of any deal will be the same as most deals in pharmaceutical products. That is ---- 1.An upfront payment for sole rights to MED2000 ( This could quite a sum-in the multi mlillions) 2.The payment of all final trial fees to be paid by licencee. 3.Subject to final trial being succesfull with all regulatory approvals and MED2000 being commercialised Futura ro recieve a royalty on all product s sold.( Plus quite possible a further lump sum) So securing the deal is the key item-not the phase 3 trials. The name of the outlicencing company will be of importance particularly if they are a major as ths provides credibility. Also anyone prepared to sign up would be pretty sure that the final trial will be satisfactory otherwise they wouldn't do so.. Any deal is clearly linked to this current PK trial results of which are due13th April onwards. Not long to wait or buy. Its very cheap if I am right We will see !

Is Futura's share price about to fly in the next 7 days or so ?. There always has been a huge potential for Futura's products but they have never yet managed to achieve a breakthrough in licencing them. Are they about to break this loosing streak. At today's share price clearly the market does not think so-but the rewards if they do so could be huge. It's my view that with the results from the second and final phase of the PK study for MED2000 due any time from 13th April onward, that, subject to this being satisfactory, A COMMERCIAL OUTLICENCING DEAL for MED2000 ,which was said to be at an advanced stage( RNS 14th March) ,will be announced. The potential future global sales for MED 2000 is $1 Billion p.a.-that's �700 million pounds p.a. So using a 5% royalty rate on the sales it would provide an income of �35 million per annum. What could Futura be worth if this occurs. Well using a p/e ratio of 10 the company ,with minimal overheads, would be worth �350 million. That's a share price of 280p per share. Current value is �41 million and share price 34p Potential gain therefore is 8 + times todays share price. This is for MED 2000 on its own. Futura have advised that the expect the following to happen on their other products during the year as well. CSD500-Reasignment of Rights for most of Europe and USA CSD500-Launch in 6 more countries and possibly up to 13. TPR100 & TIB200 -securing of further deals in USA/Europe. Any of these would add significant more value to the share price. Speculation-A consultant to Pfizer has been involved in latest Futura trials and some of Pzifer's data is being used for comparison purposes. Is this just coincidence. With Pzifer's loss of the Viagra patent protection, MED 2000 would make the ideal replacement product with all their product knowledge, personal etc already in place. Therefore a possible deal with Pzifer- A week or two and investors could be very very happy, we will see.

Got my money back plus a couple of bob, thought I made a mistake buying -just shows you can never tell on aim.